SynSmart partners with Amporin to develop small molecule therapeutics for degenerative diseases

image credit- freepik

Mumbai-based SynSmart Rasayan Research and Swiss firm Amporin Pharmaceuticals AG have announced a collaboration to develop breakthrough small molecule therapeutics for the treatment of deadly degenerative diseases.

Under the terms of this collaboration, SynSmart will synthesise a substantial library of novel membrane-protecting molecules at its Mumbai research facility. Upon screening, the collaboration could be extended to follow-on chemistry as well as potential work in ADME-PK areas, with the intention to accelerate the project to candidate selection.

SynSmart is a boutique chemistry CRDMO offering custom synthesis, medicinal chemistry and other services to over 40+ biotech and Big Pharma Customers under FTE or FFS based business arrangements.

With a growing team of 125 chemists and capabilities in small molecules, complex peptides as well as technologies like photochemistry and flow chemistry SynSmart continues to strengthen its offerings in emerging modalities across key global markets.